Data as of Nov 26
| +0.60 / +3.48%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 18.50, with a high estimate of 22.00 and a low estimate of 17.00. The median estimate represents a +3.64% increase from the last price of 17.85.
The current consensus among 4 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.